Using of Intravenous Streptokinase in Suspected Acute Myocardial Infarction Cases in Banpong Hospital.

Abstract

          Many trials have demonstrated that fibrinolytic therapy can reduce mortality rate in patients with suspected Acute Myocardial Infarction. In Banpong hospital, using of intravenous streptokinase began since 1989 after GISSI’s reported.

          In this study, we reviewed using of intravenous streptokinase in 8 patients presented with suspected Acute Myocardial Infarction. It was found that clinical responses after using intravenous streptokinase were good in all cases even in cases with complications such as congestive heart failure, complete AV block, it can be used in the elderly and in cases that presented 6 hours after chest pain.

          No stroke seen, 1 case had chest pain, 2 cases had fever, no other side effect or allergic  symptoms.

          Problem in using fibrinolytic therapy is expensive prices of the drugs. But the result of this therapy make it useful.